JP2010520856A5 - - Google Patents

Download PDF

Info

Publication number
JP2010520856A5
JP2010520856A5 JP2009548736A JP2009548736A JP2010520856A5 JP 2010520856 A5 JP2010520856 A5 JP 2010520856A5 JP 2009548736 A JP2009548736 A JP 2009548736A JP 2009548736 A JP2009548736 A JP 2009548736A JP 2010520856 A5 JP2010520856 A5 JP 2010520856A5
Authority
JP
Japan
Prior art keywords
ligand
metal ion
polyoxohydroxy
modified
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009548736A
Other languages
English (en)
Japanese (ja)
Other versions
JP5756598B2 (ja
JP2010520856A (ja
Filing date
Publication date
Priority claimed from GBGB0702270.0A external-priority patent/GB0702270D0/en
Application filed filed Critical
Priority claimed from PCT/GB2008/000408 external-priority patent/WO2008096130A1/en
Publication of JP2010520856A publication Critical patent/JP2010520856A/ja
Publication of JP2010520856A5 publication Critical patent/JP2010520856A5/ja
Application granted granted Critical
Publication of JP5756598B2 publication Critical patent/JP5756598B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009548736A 2007-02-06 2008-02-06 リガンド修飾ポリオキソヒドロキシ金属イオン物質、それらの使用およびそれらの調製方法 Active JP5756598B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US88838607P 2007-02-06 2007-02-06
US60/888,386 2007-02-06
GB0702270.0 2007-02-06
GBGB0702270.0A GB0702270D0 (en) 2007-02-06 2007-02-06 Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation
PCT/GB2008/000408 WO2008096130A1 (en) 2007-02-06 2008-02-06 Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation

Publications (3)

Publication Number Publication Date
JP2010520856A JP2010520856A (ja) 2010-06-17
JP2010520856A5 true JP2010520856A5 (enExample) 2011-03-31
JP5756598B2 JP5756598B2 (ja) 2015-07-29

Family

ID=39204358

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009548736A Active JP5756598B2 (ja) 2007-02-06 2008-02-06 リガンド修飾ポリオキソヒドロキシ金属イオン物質、それらの使用およびそれらの調製方法

Country Status (15)

Country Link
US (1) US8058462B2 (enExample)
EP (1) EP2125847B1 (enExample)
JP (1) JP5756598B2 (enExample)
KR (1) KR101514470B1 (enExample)
AU (1) AU2008212653B2 (enExample)
BR (1) BRPI0807212B1 (enExample)
CA (1) CA2676146C (enExample)
CY (1) CY1116590T1 (enExample)
EA (1) EA019635B1 (enExample)
GB (1) GB2451713B (enExample)
HR (1) HRP20150944T1 (enExample)
IL (1) IL199901A (enExample)
MX (1) MX2009008281A (enExample)
PL (1) PL2125847T3 (enExample)
WO (1) WO2008096130A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20150944T1 (hr) 2007-02-06 2015-10-09 Medical Research Council Materijali poli-okso-hidroksi-metalnih iona modificirani ligandima, njihove uporabe i postupci za njihovu proizvodnju
GB0814326D0 (en) * 2008-08-05 2008-09-10 Medical Res Council Phosphate binding materials and their uses
GB201101299D0 (en) * 2011-01-25 2011-03-09 Medical Res Council Oxygen sensors and their uses
GB201507002D0 (en) * 2015-04-24 2015-06-10 Medical Res Council Copper Oxo-hydroxide nanoparticles and their uses as biocidal agents
GB201517893D0 (en) * 2015-10-09 2015-11-25 Medical Res Council Methods for producing carboxylate ligand modified ferric iron hydroxide colloids
WO2017167970A1 (en) 2016-03-31 2017-10-05 Medical Research Council Methods for producing ferric maltol compositions from ferrous hydroxides
US11267836B2 (en) * 2016-03-31 2022-03-08 Shield TX (UK) Limited Methods for producing ferric maltol compositions from ligand modified and ligand coated ferric hydroxides
SG10202100422VA (en) 2016-08-10 2021-02-25 Res & Innovation Uk Compositions comprising nanosilica particles and their use in methods of activating t lymphocytes for therapy
ES3009466T3 (en) 2017-09-11 2025-03-27 Pharmacosmos Holding As Iron complex compounds for therapeutic use
GB202005054D0 (en) * 2020-04-06 2020-05-20 Nemysis Ltd Carboxylate Ligand Modified Ferric Iron Hydroxide Compositions for Use in the Treatment or Prevention of Iron Deficiency Associated with Liver Diseases
US20230338545A1 (en) * 2020-09-17 2023-10-26 Syracuse University Complexes of magnesium maltol (3-hydroxy-2-methyl-4h-pyran-4-one) for oral supplementation
CA3226771A1 (en) 2021-08-03 2023-02-09 Pharmacosmos Holding A/S Iron complex compounds for subcutaneous use in therapy of iron deficiency in companion animals
WO2026017901A1 (en) 2024-07-18 2026-01-22 Malian Biologicals Gmbh Iron supplementation in neurodevelopmental or psychiatric disorder

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL264270A (enExample)
US2575347A (en) 1949-07-14 1951-11-20 Interchem Corp Metallo organic compounds
GB959282A (en) 1959-08-19 1964-05-27 Hardman & Holden Ltd Improvements relating to organic aluminium compounds
US3076798A (en) 1961-02-23 1963-02-05 Hausmann Lab Ltd Process for preparing a ferric hydroxide polymaltose complex
US3679377A (en) 1970-02-17 1972-07-25 Union Oil Co Iron complexes containing aquo,sulfate and hydroxyl ligands
US3821192A (en) 1971-08-18 1974-06-28 Central Pharmacal Co Process for preparing an iron-saccharide complex
US4162986A (en) * 1977-06-20 1979-07-31 Mooney Chemicals, Inc. Oil-soluble high metal content transitional metal organic oxy, hydroxy, complexes
US4137359A (en) * 1977-10-31 1979-01-30 Mooney Chemicals, Inc. Elastomers with improved metal adhesion
DE4239442C2 (de) 1992-11-24 2001-09-13 Sebo Gmbh Verwendung eines mit polynuklearen Metalloxidhydroxiden modifizierten Adsorptionsmaterials zur selektiven Elimination von anorganischem Phosphat aus proteinhaltigen Flüssigkeiten
US6177581B1 (en) 1999-10-12 2001-01-23 The Dow Chemical Company Mixed-metal chelates and process for the preparation thereof
US20030049284A1 (en) 2001-09-05 2003-03-13 Boccio Jose Ruben Method of increasing the solubility of alphahydrocarboxilic salts, and products obtained by the method
BR0212542B1 (pt) 2001-10-08 2014-04-08 Purac Biochem Bv Método para a preparação de gluconato de cálcio, mistura de sal de gluconato/sal de ácido orgânico, lactato/gluconato de cálcio, produto de alimento fortificado com cálcio, e, suco de laranja
US6770773B2 (en) * 2002-01-24 2004-08-03 William Marsh Rice University Organic acid-Fe-OOH (ferroxane) particles and ferroxane-derived ceramics and ceramic membranes
US7994217B2 (en) 2002-05-02 2011-08-09 Xanodyne Pharmaceuticals, Inc. Prenatal multivitamin/multimineral supplement
GB0211500D0 (en) 2002-05-18 2002-06-26 Vitra Pharmaceuticals Ltd Method of forming iron hydroxypyrone compounds
DE10249552A1 (de) 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
US6706904B1 (en) 2002-12-04 2004-03-16 Albion International, Inc. Dimetalhydroxy malates
TWI335218B (en) 2003-02-19 2011-01-01 Panion & Bf Biotech Inc Ferric organic compounds, uses thereof and methods of making same
US7964568B2 (en) 2003-05-30 2011-06-21 Chromaceutical Advanced Technologies, Inc. Synthesis of high molecular weight iron-saccharidic complexes
US7674780B2 (en) 2004-03-16 2010-03-09 Navinta Llc Iron sucrose complexes and method of manufacture thereof
WO2005094203A2 (en) 2004-03-16 2005-10-13 Navinta, Llc Sodium ferric gluconate complexes and method of manufacture thereof
MX2007004036A (es) 2004-10-08 2007-05-24 Unilever Nv Complejo de hierro para uso en el tratamiento y/o prevencion de trastornos nutricionales.
DE202005014332U1 (de) 2005-09-09 2006-01-19 Institut für Oberflächenmodifizierung e.V. Metallorganisches Nanopulver
HRP20150944T1 (hr) 2007-02-06 2015-10-09 Medical Research Council Materijali poli-okso-hidroksi-metalnih iona modificirani ligandima, njihove uporabe i postupci za njihovu proizvodnju
TWI468167B (zh) 2007-11-16 2015-01-11 威佛(國際)股份有限公司 藥學組成物
GB0814326D0 (en) 2008-08-05 2008-09-10 Medical Res Council Phosphate binding materials and their uses

Similar Documents

Publication Publication Date Title
JP2010520856A5 (enExample)
HRP20150944T1 (hr) Materijali poli-okso-hidroksi-metalnih iona modificirani ligandima, njihove uporabe i postupci za njihovu proizvodnju
Yoon et al. Surface modification of exfoliated layered gadolinium hydroxide for the development of multimodal contrast agents for MRI and fluorescence imaging
CN103566906B (zh) 一种磁性壳聚糖纳米颗粒吸附剂及其制备方法与应用
CN102143742B (zh) 磷酸盐结合材料及其用途
Velho-Pereira et al. Antibacterial action of doped CoFe2O4 nanocrystals on multidrug resistant bacterial strains
Cho et al. Preparation and characterization of MRI-active gadolinium nanocomposite particles for neutron capture therapy
CN104311579A (zh) 间苯二甲酸-5-磺酸铜配合物及其制备方法
Yamada et al. Synthesis of luminescent Eu (III)-doped octacalcium phosphate particles hybridized with succinate ions and their reactive behavior in simulated body fluid
JP2008530065A5 (enExample)
AU2001279994B2 (en) Trace elements
JP2014224258A (ja) 金属結晶含有のアルギン酸モノマー、金属結晶含有のアルギン酸塩モノマー及び金属結晶含有のアルギン酸塩ヒドロゲル及びその製造方法
CN104591295B (zh) 一种超顺磁铁氧体纳米粒子的制备方法
Teng et al. Ligand exchange triggered controlled-release targeted drug delivery system based on core–shell superparamagnetic mesoporous microspheres capped with nanoparticles
TW201622756A (zh) 抗菌複合材料及其製造方法
CN103191049A (zh) 一种替加氟/类水滑石纳米杂化物与磁性基质的复合物及其制备
JP6730958B2 (ja) ベンゼンポリカルボン酸化合物及びその薬剤としての使用
TWI357887B (enExample)
Mei et al. White luminescent hybrid soft materials of lanthanide (Eu3+, Sm3+) beta-diketonates and Ag/Ag2S nanoparticles based with thiol-functionalized ionic liquid bridge
CN119873756A (zh) 一种过氧化锶纳米材料及其制备方法和应用
CN115505384B (zh) 一种酸化压裂液用高温铁离子稳定剂
KR101107553B1 (ko) 2가지 이상의 금속이 결합된 수산화물 계열 전구체의 표면 개질을 통한 유용성 입자 제조방법
CN112195026B (zh) 一种铕掺杂β-磷酸三钙荧光纳米颗粒及其制备方法和应用
JP6074278B2 (ja) 改質無機酸化物粒子
Rzączyńska et al. Thermal and spectroscopic properties of light lanthanides (III) and sodium complexes of 2, 5-pyridinedicarboxylic acid